Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial.

Lluis L PuigAntonio CostanzoElke M G J de JongTiago TorresRichard B WarrenRobert WapenaarSven WegnerPatricia GoreckiTalia GramicciaMaria JazraJozefien BuyzeCurdin Conrad

Published in: American journal of clinical dermatology (2023)

NCT02207231.

Keyphrases

clinical trial
coronary artery disease
soft tissue
phase ii
wound healing
open label
gestational age
study protocol
double blind
phase iii
atopic dermatitis
newly diagnosed